Vevzuo 120 mg/1.7 ml (70 mg/ml), Injektionslösung

7680701420012 CH-70142 Injektionslösung

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
denosumabum
120.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
natrium
0.5 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
sorbitolum
79.9 MG Substance HBESI
polysorbatum 20
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum aceticum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
70142
Drug name
Vevzuo, Injektionslösung
Galenic form
LSINJ
ATC Code
M05BX04
Authorization status
Z
Dispensing category
A
First authorization
18/11/2025
Authorization expiration date
17/11/2030
IT Number
07.16.1.
Domain
Human medicine
Field of application
Knochenmetastasen solider Tumoren; Riesenzelltumoren des Knochens

Package details

Description (FR)
VEVZUO 120 mg/1.7 ml sol inj flac perf 1 pce
Description (DE)
VEVZUO 120 mg/1.7 ml Inj Lös Durchstf 1 Stk
Market launch
01/10/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data